Krystal Biotech, Inc.

KRYS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$79$38$36$45
Dep. & Amort.$2$2$2$2
Deferred Tax-$25$0$0$0
Stock-Based Comp.$0$14$13$13
Change in WC-$28$0-$19-$6
Other Non-Cash$11-$2-$1-$2
Operating Cash Flow$40$53$31$53
Investing Activities
PP&E Inv.-$2-$2-$6-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$98-$114-$138-$143
Inv. Sales/Matur.$96$105$89$60
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$4-$11-$55-$84
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$2$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$12$2
Financing Cash Flow$4$2-$12$2
Forex Effect-$0$1$0-$1
Net Chg. in Cash$39$45-$36-$29
Supplemental Information
Beg. Cash$354$309$345$374
End Cash$393$354$309$345
Free Cash Flow$38$51$25$52
Krystal Biotech, Inc. (KRYS) Financial Statements & Key Stats | AlphaPilot